Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Neoplasms, Basal Cell: later-stage trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Neoplasms, Basal Cell: 1 US clinical trial tracked, none currently recruiting.

Neoplasms, Basal Cell is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is VA Office of Research and Development, running 1 of these trials.

Enrollment posture brief

Registry condition neoplasms-basal-cell

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Neoplasms, Basal Cell (this)0%
Open-enrollment share among volume-matched conditions near Neoplasms, Basal Cell

Neoplasms, Basal Cell has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Neoplasms, Basal Cell on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Neoplasms, Basal Cell is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Neoplasms, Basal Cell records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo, vehicle control Drug
1 trials
5-fluorouracil Drug
1 trials

US sites by state

Facility locations filed on Neoplasms, Basal Cell trials. A trial with sites in several states counts in each.

Tennessee 1 trials
Rhode Island 1 trials
Pennsylvania 1 trials
North Carolina 1 trials
Minnesota 1 trials
Massachusetts 1 trials
Illinois 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Neoplasms, Basal Cell page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neoplasms, Basal Cell condition card totals 1 registered trials; most-linked intervention Placebo, vehicle control; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.